ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1159

Transcription Factor SOX5 Promotes Rheumatoid Arthritis Synovial Fibroblast Migration and Invasion By Regulating MMP9 Expression

Wenfeng Tan1, Yumeng Shi2, Xiaoke Feng2, Fang Wang2, Xiaoxi Wang2, Qiuyue Peng2, Wenhua Xuan2 and zhang miaojia3, 1Rheumatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China, 2the First Affiliated Hospital of Nanjing Medical University, Nanjing, China, 3the First Affiliated Hospitial of Nanjing Medical University, Nanjing, China

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: transcription factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

SOX5 is known as a transcription factor which primarily involved in in the regulation of embryonic development, cell fate, and chondrogenesis. To date,  little is known the effect of SOX5 on rheumatoid arthritis (RA). We previously reported a RANKL promoter SNP confers an elevated promoter activity after stimulation via binding to a SOX family transcription factor SOX5 and is associated with younger age at onset of rheumatoid arthritis (RA) (Arthritis Rheum 2010; 62(10):2864-75.). Subsequently, we confirmed that SOX5 could up-regulate RANKL expression in RA synovial fibroblast(SF) and participate in the bone erosion of RA. Here, we examine the effect of SOX5 on the migration and invasive characteristics of RA synovial fibroblasts.

Methods:

Rheumatoid synovial fibroblasts cell line MH7A were treated with SOX5 small interfering RNA (SOX5-siRNA) and recombinant Adenovirus SOX5 expression vectors (Ad-SOX5). Migration and invasion and of RASF was assessed by transwell matrigelTMinvasion chambers and collagen gel assays. Modulation of MMP9 expression in RASF was analyzed by real-time PCR, western blot and luciferase assay. Collagen-induced arthritis (CIA) DBA/1 mouse locally injected with lentivirus-shSOX5 was used to examine the effect of SOX5 on MMP9 expression in vivo.  

Results:

Overexpression of SOX5 significantly promoted cell migration, invasion and MMP-9 expression in RASF. Migration and invasion of RASF was markedly decreased by silencing SOX5 expression in RASF but could be reverted by added the recombinant MMP9 cytokine into RASF. Overexpression of SOX5 enhanced the promoter activity of MMP9 in Hela cell. Local silencing SOX5 in CIA mice inhibited the synovitis and bone erosion  and accompanied by the  reduced MMP9 expression in synovium of CIA mice.

Conclusion:

These findings indicate transcription factor SOX5 plays an important role in  regulating  RASF migration and invasion by modulation MMP9 expression, suggesting SOX5 as a potential therapeutic target for the treatment of RA.


Disclosure: W. Tan, None; Y. Shi, None; X. Feng, None; F. Wang, None; X. Wang, None; Q. Peng, None; W. Xuan, None; Z. miaojia, None.

To cite this abstract in AMA style:

Tan W, Shi Y, Feng X, Wang F, Wang X, Peng Q, Xuan W, miaojia Z. Transcription Factor SOX5 Promotes Rheumatoid Arthritis Synovial Fibroblast Migration and Invasion By Regulating MMP9 Expression [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/transcription-factor-sox5-promotes-rheumatoid-arthritis-synovial-fibroblast-migration-and-invasion-by-regulating-mmp9-expression/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcription-factor-sox5-promotes-rheumatoid-arthritis-synovial-fibroblast-migration-and-invasion-by-regulating-mmp9-expression/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology